About Enhancer
Enhancer ID: |
E_01_0831 |
Species: |
human |
Position :
|
chr12:55964237-55966237  |
Biosample name: |
|
Experiment class :
|
High+Lowthroughput |
Enhancer type: |
Enhancer |
Disease: |
Nonalcoholic fatty liver disease |
Pubmed ID: |
33334026
|
Enhancer experiment: |
Tag accumulation, staining and high content imaging, real time PCR, dendrogram � hierarchical clustering using Ward's method |
Enhancer experiment description: |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About Target gene
Target gene : |
CDK2 |
Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: |
RNA-Seq |
Target gene experiment description: |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About TF
TF name : |
-- |
TF experiment: |
TAG?????????????????? PCR????�??????????? |
TF experiment description: |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About Function
Enhancer function : |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function experiment description: |
Non-alcoholic fatty liver disease (NAFLD) has a large impact on global health. At the onset of disease, NAFLD is characterized by hepatic steatosis defined by the accumulation of triglycerides stored as lipid droplets. |
About SNP
Upstream Pathway Annotation of TF
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs